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Wound careAbstract Fungal mycelium capable of producing antibacterial agents was isolated from samples of
apple, beetroot, lemon and orange; the mycelium of all isolates produced penicillin, while the apple
and beetroot samples also produced the antibacterial mycotoxin patulin. The known penicillin-
producing fungi were shown to produce penicillin, but not patulin. The mycelial discs of all of fruit
and vegetable isolates, as well as the two known penicillin producing fungi, inhibited Staphylococcus
aureus, and mycelium of all isolates inhibited MRSA, in contrast, only one of the two known
penicillin-producers did so. The results are discussed in relation to the possibility of using the
mycelium of Penicillium species in mycotherapy.
ª 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Moulds (i.e. ﬁlamentous fungi) were widely used as curative
agents in all of the world’s cultures well before Fleming’s
famous discovery of penicillin in 1928. Imhotep, an ancient
Egyptian practitioner, for example, used mouldy bread to treat
infections of the face (Wainwright et al., 1992). The literature
from more recent folk medicine has documented some other
examples of the use of moulds on infections. For example,
mouldy jam and mouldy bread were widely used in folk-
based therapy in Quebec (Canada), Devon (UK), and
Kansas (USA) and poultices made from mouldy chewed barley
and apple have long been used in Asia to cure surface wounds.
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have a curative effect when applied to infections (Wainwright,
1989).
The difﬁculties facing researchers attempting the large scale
production of penicillin during 1940s encouraged some hospi-
tal scientists to re-evaluate the therapeutic properties of crude
penicillin ﬁltrates (Wainwright et al., 1992; Dunayer et al.,
1994; Enoch and Wallersteiner, 1994; Robinson and Wallace,
1943; Wainwright, 1987, 1994, 1998); a number of different
methods were used including the topical application of crude
penicillin involving (a) the application of bandages saturated
with liquid ﬁltrates or (b) dressings inoculated with the
penicillin-producing mould Penicillium notatum (Wainwright,
1987). Although many successful cures were achieved using
crude penicillin, its unregulated production and potential
problems relating to contamination and purity caused concern
and, not surprisingly, it became completely redundant once
puriﬁed penicillin became widely available (Wainwright,
1987). Wainwright et al. (1992) investigated the scientiﬁc basis
of the mycotherapy and their results suggest that the active
agent responsible for the observed curative effects is patualin,
and not penicillin.
The aim of the work reported here was to determine if fun-
gal mycelium, grown from moulds isolated from mouldy
foods, is (1) able to produce both penicillin and patulin and
(2) whether they produce agents capable of inhibiting the
growth of Staphylococcus aureus and MRSA. It is hoped that
these studies will give impetus to medical scientists to consider
the re-introduction of mycotherapy into modern medicine.
2. Experimental section
The following test bacteria were used: methicillin-sensitive
Staphylococcus aureus (MSSA) and methicillin-resistant
Staphylococcus aureus (MRSA); unless stated otherwise, the
organisms were obtained from the Departmental Culture
Collection. A variety of naturally mouldy vegetables and fruits
were collected from local retail outlets; i.e. apple, oranges, lem-
ons and beetroot. Two known penicillin-producing fungi,
Penicillium chrysogenum (IMI 37767) and P. chrysogenum
(IMI 24317), were also included.
The fungi were isolated from a variety of collected mouldy
foods. Either skin (2 · 2 mm) or heavily sporulating colonies
were picked off, to Czapek Dox liquid medium (Oxoid) and
incubated at 25 C with shaking 150 rpm for two weeks.
The isolated fungal cultures were then identiﬁed after visu-
alisation under a low power microscope and grown as
described in the above method. The mycelia of these cultures
were separated by ﬁltering using Whatman ﬁlter paper. The
antibacterial activity of the harvested mycelia was then deter-
mined by placing a disc of fungal mycelia on Nutrient Agar
(Oxoid) plates which had been previously covered with a
culture of either MSSA or MRSA. Plates were incubated at
37 C for 24 h. The diameter of the inhibition zone (mm)
produced was then measured.
The contents of all growth fungi liquid culture ﬂasks were
ﬁltered using Whatman No. 1 ﬁlter paper and the mycelium
was transferred into 250 ml separating funnel contained two
equal volumes of ethyl acetate. The separating funnel was
shaken for 2 min and the contents were allowed to settle and
layers separated. The bottom aqueous (fungal culture) layerwas removed and discarded, while the top layer (ethyl acetate)
was collected and combined with 2 g of anhydrous sodium sul-
phate (Na2SO4), then left to evaporate to dryness.
Patulin was detected using thin layer chromatography
(Gimeno, 1979; Gimeno and Martings, 1983), Sigma–
Aldrich TLC plates, cellulose matrix, H ·W 10 cm · 20 cm
with a ﬂuorescent indicator were used as a stationary phase.
Two 10 ll aliquots of extracts were spotted along a line 3 cm
from the lower edge of the plate. 5 ll of patulin standard were
spotted as a reference standard solution. The plates were then
placed in Latch-lid TLC chambers (Aldrich) for one dimen-
sional development for about 2 h in benzene:methanol:acetic
acid – BMA (90:5:5 v/v/v)(mobile phase); they were then left
at room temperature until the solvent front had reached a line
marked 2 cm from the top of the plate. The plates were then
removed and air-dried in a fume cabinet and sprayed with a
freshly prepared mixture of 0.5 ml p-anisaldehyde (in 85 ml
of methanol containing 10 ml of glacial acetic acid and 5 ml
of concentrated sulphuric acid) and then heated at 110 in a
hot-air oven for 10 min. Plates were then were visualised using
a 2UV Transilluminator (300–360 nm).
After being air-dried and sprayed with a fresh preparation
of p-anisaldehyde (Fluka), developed chromatograms were
viewed under visible and UV light for the presence of ﬂuores-
cent spots. The p-anisaldehyde spray allows patulin to be
detected as faint brown spots under visible light and as
yellow-orange under UV light. According to Scott et al.,
1970 using ethanol instead of methanol in the spray reagent
will improve the detection of patulin at a detection limit of
0.1 lg (Scott and Somers, 1968; Scott et al., 1970).
The SNAP MRL Beta-Lactam Kit (IDEXX, USA) was
used to test for the presence of betalactams; it depends on an
enzyme-linked receptor-binding assay, designed to detect most
beta-lactam antibiotics, notably penicillin G. The Kit contains:
a SNAP Device, a sample tube containing reagent pellet, a
pipette, SNAP positive controls and a heater block capable
of maintaining an operating temperature of 45 C+ 5 C.
The heater block used was preheated to 45 C+ 5 C, the
SNAP device, the pipette and sample tube were removed from
the bag and the reagent pellet was checked to be present at the
bottom of the sample tube. The SNAP device was then placed
in the heater block; 2 ml of the liquid culture (sample), shaken
thoroughly, and then the sample tube cap was removed and
discarded, 450 ll of the sample was drawn up with the
IDEXX pipette, the sample was then added carefully from
the pipette to the tube. To dissolve the reagent pellet the
sample tube was shaken. The sample tube was then incubated
in the preheated heater block at 45 C for 5 min.
The contents of the sample tube were poured into the
sample well of the SNAP device, and the tube was discarded.
The sample ﬂowed across the results window towards the blue
activation circle. When the blue activation circle began to dis-
appear, the activator button was pushed ﬁrmly until it snapped
ﬂush with the body of the SNAP device, during colour
development the SNAP device was left in the heater block;
after 4 min, the result was ready to be read.
3. Results and discussion
The ability of mycelium of Penicillium species to inhibit both
methicillin sensitive (MSSA) and methicillin resistant S. aureus
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an illustration of the zones produced on the test plate is also
shown in Fig. 1. As expected, a paper test disc containing peni-
cillin was shown to inhibit MSSA, but not MRSA. Mycelium
from all of the Penicillium cultures isolated from foods inhib-
ited both MSSA and MRSA. The obvious question is what
antibacterial agent is responsible for this inhibition? Tests
using SNAP (Fig. 2) to test for penicillin and TLC for patulin
showed that penicillin was found in culture ﬁltrates from all of
the individual fungi, while patulin was produced by the apple
and beetroot isolates. The isolation of a patulin-producing
fungus from apples is to be expected since patulin is commonly
produced on both apples and in apple juice (Brian et al., 1956;
Bilai, 1963; Wilson and Nuovo, 1973).
Although penicillin and patulin were tested here it is, of
course, possible that other antibacterial agents were also pro-
duced which act alone, or together with penicillin or patulin
to inhibit the MSSA or MRSA. This would explain how the
MRSA was inhibited when this organism is known to be resis-
tant to penicillin. In relation to mycotherapy, one could ask
the question-is the nature of the antibacterial agent or agents
produced by the mycelium important? Certainly from a nor-
mal clinical viewpoint, a clinician would be expected to know
what agents are being produced by a mould which is being
used to treat a wound. This is especially true in the case of
Penicillium species which are known to produce various poten-
tially dangerous toxic mycotoxins. Patulin, for example, isTable 1 Antibacterial activity of the mycelial discs (zone of
inhibition, mm) of Penicillium cultures and isolates from
foodstuffs.
Test MSSA MRSA Penicillin Patulin
Penicillin G disc (6 lg) 30 0 + 
P. chrysogenum (IMI
24317)
26 0 + 
P. chrysogenum (IMI
37767)
14 15 + 
Penicillium sp. (apple) 16 17 + +
Penicillium sp. (beetroot) 17 18 + +
Penicillium sp. (lemon) 18 17 + 
Penicillium sp. (orange) 19 18 + 
Figure 1 The antibacterial activity of mycelia (M) and the
ﬁltrates (F) of the fungus was isolated from apple liquid culture
against MRSA.
Figure 2 The SNAP device showing different results according
to samples sources. Note in positive control, lemon and beetroot
samples, the control spots are darker than the sample spot
(positive results), whereas in the negative control (sterilised
Czapek Dox liquid medium) the control spot was lighter than
the sample spot.toxic and its long term intake into the body may lead to the
formation of cancers (Reddy et al., 1978). As was discussed
in the Introduction, mycelium of Fleming’s penicillin-
producing mould was successfully applied to infected wounds
during the mid to late 1940s, where it proved to be highly suc-
cessful, although its use soon relegated to a historical artefact
once puriﬁed penicillin became widely available. There appears
therefore following controlled clinical trials, such mycotherapy
might be re-introduced into modern medicine especially since
some, newly isolated, penicillin-producing moulds might pro-
duce antibacterial agents other than penicillin, which might
inhibit the growth of MRSA in infected wounds. During clin-
ical experience gained in the period when P. notatum was used
as a ﬁltrate, as macerated mycelium in ﬁltrates, or when grow-
ing on agar or other substrates applied to wounds exposed no
examples of toxic contradictions (Wainwright et al., 1992). The
application to wounds, of a mould which is known to produce
penicillin and or patulin, as well as other unknown antibacte-
rial (or otherwise) compounds would obviously be initially dis-
missed by regulatory authorities and would not pass ethical
panel scrutiny.
Under what conditions might moulds, isolated from com-
mon foods, be used to treat wounds infected with S. aureus,
including MRSA?
Clearly then, a pure culture of a Penicillium, known to pro-
duce penicillin and not patulin or other toxicants (like the two
IMI strains used here) could be safely used to treat wound
infections in hospitals at the present time. Finally, can a
Figure 3 Simulated treatment of a wrist wound with surface
grown mycelium of an antibacterial agent-producing strain of a
Penicillium species.
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study could be put to practical use?
The obvious answer is that Penicillium moulds isolated
from mouldy foods could be applied to wounds in extremis,
that is when no other medical intervention is available to treat
an infected wound, e.g. following an event which leads to the
total breakdown of society (e.g. after a nuclear war, or during
local extreme living conditions such as in prisoner of war
camps. Under these conditions, Penicillium cultures could be
isolated from mouldy foods (a mixture of such moulds from
various foods might prove particularly effective) and could
be applied to wounds (Fig. 3) in the knowledge that they
would contain penicillin and or patulin, plus other antibacte-
rial metabolites. Under such extreme condition such metabo-
lites could prove the difference between life and death for a
patient suffering from a critically infected wound.
Alternatively, under these circumstances food-related moulds
could be applied prophylactically to prevent the development
of an infection in an open wound.
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